MGMT and neoplasm: Although MGMT inhibitors are not routinely applied in melanoma therapy, the conclusions can be translated to the therapeutic situation as TMZ/DTIC is being used daily, which is supposed to cause a depletion of MGMT in tumor cells and MGMT in melanoma has been shown to be predictive of outcome [38].